Travoprost Market In Global
Travoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent ... Read More
Wogonoside, a flavanoid, is known for its anti-inflammatory properties. Wogonoside may have therapeutic potential for use in diseases which involve the development of inflammation and angiogenesis through its inhibition of LPS-induced angiogenesis.
This report contains market size and forecasts of Wogonoside in global, including the following market information:
Global Wogonoside Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Wogonoside Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Wogonoside companies in 2021 (%)
The global Wogonoside market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wogonoside include Merck, TCI, BioVision, Abcam, LGC, BOC Sciences, LifeSpan BioSciences, Cayman Chemical and Adooq Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Wogonoside manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wogonoside Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Wogonoside Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Wogonoside Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Wogonoside Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Wogonoside Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Wogonoside Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wogonoside revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Wogonoside revenues share in global market, 2021 (%)
Key companies Wogonoside sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Wogonoside sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
TCI
BioVision
Abcam
LGC
BOC Sciences
LifeSpan BioSciences
Cayman Chemical
Adooq Bioscience
Clearsynth
AbMole
Selleck Chemicals
LKT Laboratories
Travoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent ... Read More
Travoprost is a potent and selective FP prostaglandin receptor agonist used for the treatment of ... Read More
Cloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and ... Read More
Cloprostenol sodium salt hydrate is a potent FP prostanoid receptor agonist which is 2- to 3-fold ... Read More